Development of a Thalassemia International Prognostic Scoring System (TIPSS)

Abstract

A prognostic scoring system that can differentiate β-thalassemia patients based on mortality risk is lacking. We analysed data from 3145 β-thalassemia patients followed through a retrospective cohort design for the outcome of death. An a priori list of prognostic variables was collected. β Coefficients from a multivariate cox regression model were used from a development dataset (n = 2516) to construct a formula for a Thalassemia International Prognostic Scoring System (TIPSS) which was subsequently applied to a validation dataset (n = 629). The median duration of observation was 10.0 years. The TIPSS score formula was constructed as exp (1.4 × heart disease + 0.9 × liver disease + 0.9 × diabetes + 0.9 × sepsis + 0.6 × alanine aminotransferase ≥42 IU/L + 0.6 × hemoglobin ≤9 g/dL + 0.4 × serum ferritin ≥1850 ng/mL). TIPSS score thresholds of greatest differentiation were assigned as <2.0 (low-risk), 2.0 to <5.0 (intermediate-risk), and ≥5.0 (high-risk). The TIPSS score was a good predictor for the outcome of death in the validation dataset (AUC: 0.722, 95%CI: 0.641–0.804) and survival was significantly different between patients in the three risk categories (P < 0.001). Compared to low-risk patients, the hazard ratio for death was 2.778 (95%CI: 1.335–5.780) in patients with intermediate-risk and 6.431 (95%CI: 3.151–13.128) in patients with high-risk. This study provides a novel tool to support mortality risk categorization for patients with β-thalassemia that could help management and research decisions. © 2022

Description

Keywords

Management, Mortality, Outcomes, Prognosis, Survival, Thalassemia, Beta-thalassemia, Humans, Portasystemic shunt, transjugular intrahepatic, Retrospective studies, Alanine aminotransferase, Ferritin, Hemoglobin, Adult, Beta thalassemia, Clinical outcome, Cohort analysis, Controlled study, Data analysis, Diabetes mellitus, Diagnostic test accuracy study, Female, Ferritin blood level, Hazard ratio, Heart disease, High risk patient, Human, Intermediate risk patient, International prognostic scoring system, Liver disease, Low risk patient, Major clinical study, Male, Mortality risk, Outcome assessment, Receiver operating characteristic, Regression model, Retrospective study, Review, Risk assessment, Sensitivity and specificity, Sepsis, Validation process, Adverse event, Complication, Transjugular intrahepatic portosystemic shunt

Citation

Endorsement

Review

Supplemented By

Referenced By